Abstract
Simple Summary
Regeneration represents the biological processes that allow cells and tissues to renew and develop. During obesity, a variety of changes and reactions are seen. This includes inflammation and metabolic disorders. These obesity-induced changes do impact the regeneration processes. Such impacts that obesity has on regeneration would affect tissues and organs development and would also have consequences on the outcomes of therapies that depend on cells regeneration (such as burns, radiotherapy and leukemia) given to patients suffering from obesity. Therefore, a particular attention should be given to patients suffering from obesity in biological, therapeutic and clinical contexts that depend on regeneration ability.
Abstract
Obesity is a health problem that, in addition to the known morbidities, induces the generation of a biological environment with negative impacts on regeneration. Indeed, factors like DNA damages, oxidative stress and inflammation would impair the stem cell functions, in addition to some metabolic and development patterns. At the cellular and tissulaire levels, this has consequences on growth, renewal and restoration which results into an impaired regeneration. This impaired homeostasis concerns also key metabolic tissues including muscles and liver which would worsen the energy balance outcome towards further development of obesity. Such impacts of obesity on regeneration shows the need of a specific care given to obese patients recovering from diseases or conditions requiring regeneration such as burns, radiotherapy and leukemia. On the other hand, since stem cells are suggested to manage obesity, this impaired regeneration homeostasis needs to be considered towards more optimized stem cells-based obesity therapies within the context of precision medicine.
Keywords: obesity, regeneration, homeostasis
Endogenous processes and biological homeostasis require a proper regeneration ability summarized in the biological capacity to restore, renew and grow different cells and tissues. This regeneration ability (governed by complex cellular functions and molecular processes) requires optimum conditions defined by biological environments in terms of pH, cytokines, growth factors and diverse signals and messenger activities.
Within this context, obesity, as a pathological status of broken homeostasis [1,2], induces the generation of a negative regeneration environment, which, biologically, means conditions that limit or reduce the ability of cellular and tissulaire restoration, renewal and growth. Indeed, diverse works throughout the literature report direct and indirect impacts of obesity on regeneration in different cells and tissues. Stem cells are key players for regeneration and these cells are impacted by obesity. For instance, data indicate that stem cells-based hematopoietic and osteogenic regeneration is impaired during obesity [3], probably as a consequence of bone marrow adipose tissue expansion that leads to a deterioration within the skeleton [4], the obesity-induced bone marrow microenvironment modifications [5] and the increased endoplasmic reticulum stress in bone marrow mesenchymal stem cells [6]. In addition, proliferative and migratory abilities of adipose-derived mesenchymal stem cells derived from obese subjects are reduced [7]. Obesity also alters the stem cells’ differentiation potential [8]. These obesity impacts on stem cells might result from different mechanisms, including the reshape of stem cell extracellular vesicles [9], inflammation promotion [5] and the resulting surrounding microenvironment modifications resulting from obesity [10,11]. Within this context, it is worth mentioning that during obesity, inflammatory-related balance is impaired. Indeed, M1 macrophages (promote pro-inflammation) are enhanced and M2 macrophages (anti-inflammatory factor) are down-regulated [12]. Such macrophage polarization supports the classification of obesity as a chronic pro-inflammatory disease [12] leading to metabolic dysfunctions, including insulin resistance [13]. To further understand the critical balanced roles of inflammation, it is essential to state that although obesity-induced inflammation might impair regeneration, inflammatory-related processes such as those mediated by macrophages are required for damaged tissue elimination as a step preparing the regeneration as explored by Varga T et al. [14,15,16].
Regarding skeletal muscles, which form the locomotor system with the skeleton, their regeneration is also impaired by obesity [17]. Importantly, satellite cells (muscle stem cells) are reduced in obese mice (post trauma [18]) with a diminished fusion capacity [19], showing the deep impacts of obesity on muscle regeneration starting at the stem cell level. Moreover, this obesity senescence has also been said to affect satellite cells and skeletal muscle in the context of obesity [20], which indicates the worsening effect ageing has on regeneration.
Within the metabolics of skeletal muscle, the expression of the mitochondrial glycerol 3-phosphate dehydrogenase (which promotes skeletal muscle regeneration) is reduced in animal models of obesity [21]. Such mitochondrial implications are in correlation with the suggested regulatory role mitochondrial biogenesis plays during muscle regeneration [22,23]. These illustrations of the close links between obesity, mitochondria and skeletal muscle provide a piece, among others [24,25,26], of the mechanistic puzzle of obesity impacts on skeletal muscle regeneration from a metabolic perspective. Furthermore, the deficiency of vitamin D, which plays a role in skeletal muscle regeneration [27], is associated with obesity [28] as well.
The other important element linking obesity to the generation of an environment leading to reduced regeneration ability is inflammation detected within different tissues, including skeletal muscle [29], adipose tissue [30,31] and liver [30], which are the key metabolic tissues governing most of the energy balance homeostasis. Inflammation impairs the regeneration of the skeletal muscle [32], and these impacts, among others, that obesity has on muscle regeneration are of particular importance since muscle is the key tissue for energy expenditure. Therefore, reduced metabolic performance of the muscle would reduce the energy expenditure and worsen obesity by shifting the metabolic balance towards further energy storage. Importantly, the impact obesity has on skeletal muscle in terms of regeneration could worsen sarcopenic obesity and explain a part of its pathogenesis [33], including that shared with obesity and leading to commune outcomes such insulin resistance and cardiometabolic impacts [34], through reducing muscle regeneration in an obesity-developing environment. Exploring an example from liver’s regenerative properties, the other key metabolic organ, indicates that hepatic steatosis (which develops during obesity [35,36]) impairs liver regeneration through diverse mechanisms, including oxidative stress [37], which could worsen the existent energy balance status as well.
Selected growth and metabolic factors are also modified during obesity. For instance, insulin [38] and leptin [39] increase during obesity. Since such factors are related to cellular growth and metabolism [40,41,42,43,44], these changes could impact regeneration ability. Indeed, insulin roles within both adipocytes and bone stromal stem cells of the bone marrow [45] suggest an impact of increased insulin on both regeneration and metabolism, as illustrated by the obesity-associated hypermetabolism leading to bone fragility [46], especially with the important roles that marrow adipocytes play in bone homeostasis [47] and remodeling [48]. This fits with the findings that obese db/db (mice lacking leptin receptor) have their postnatal regenerative osteogenesis compromised [49]. More extensive investigations linking growth and homeostatic factors (hormones, neurotransmitters, metabolic mediators, etc.) changes during obesity to regeneration impairment would provide molecular links allowing better clarification of the mechanistic pathways and identify molecular targets to correct these effects on regeneration homeostasis.
In addition, obesity represents a risk factor for cancer [50], which represents a pathological cellular replication and therefore indicates a “wrong” direction of renewal and growth of cells. This could be the result of a loss of the regeneration balance resulting from obesity-induced environment impacting the regeneration or the cancer, depending on the situation, as illustrated by the links between the liver cancer progression and an abnormal microenvironment [51] or the effect of neurostimulation in both cancer and regeneration contexts, respectively [52]. Thus, understanding key differences between the physiological regeneration process and obesity-induced regeneration impairments combined with an understanding of obesity-associated cancer growth could contribute to a better understanding of carcinogenesis pathways.
Looking into subcellular and molecular pathways allows one to identify more mechanistic links between obesity and its negative impacts on regeneration. These include a reduced level of growth factors [53], altered DNA repair [54], induced DNA damage [55] and epigenetic changes [56]. This could explain the other important facts supporting the negative impacts obesity has on regeneration: reduced healing ability associated with obesity, as illustrated by the example of the slow bone fracture healing in obese mice [53], and increased risk of neurodegenerative diseases with obesity [57]. This shows the need to take particular care of obese patients recovering from diseases or conditions requiring regeneration, such as burns, radiotherapy, and leukemia, because of compromised regeneration ability.
Since stem cells are suggested to manage obesity [6,58,59], the negative environment generated by obesity could limit the efficacy of such an approach and therefore would first, as a preliminary step, reduce obesity (by diet, exercise or pharmacological tools) prior to stem cell administration, similarly to patients being prepared for bariatric surgery, in order to improve the biological environment receiving the stem cells and therefore optimize the therapeutic outcomes. In addition, since the negative impacts obesity has on regeneration are worsened by factors such as age [3], stem cell application to manage obesity should consider such factors towards more personalized stem cells-based therapies. Moreover, it is important to highlight the need for further studies to understand molecular players and allow one to define personalized treatments. The diversity of the available animal models of obesity could lead to differences in the results of obesity–regeneration interaction investigations. For instance, the use of diet-induced obesity animal models [60] would mimic obesity’s general effects, whereas the use of more specific models such as db/db or ob/ob animal models [61] would generate data closer to the effects of leptin in the obesity context.
The effects that an obesity-induced environment has on diverse regeneration patterns at different levels impact the development of different tissues as well as related metabolic, biochemical and physiological functions. Such impaired regeneration will have clinical, therapeutic and research applications and implications.
Acknowledgments
Abdelaziz Ghanemi received a merit scholarship for foreign students from the Ministry of Education and Higher Education of Quebec, Canada. The Fonds de recherche du Québec–Nature et technologies (FRQNT) is responsible for managing the program (Bourses d’excellence pour étudiants étrangers du Ministère de l’Éducation et de l’Enseignement supérieur du Québec, Le Fonds de recherche du Québec–Nature et technologies (FRQNT) est responsable de la gestion du programme).
Author Contributions
A.G. drafted the manuscript; A.G., M.Y. and J.S.-A. critically revised the manuscript. All authors have read and agreed to the published version of the manuscript.
Funding
This research received no external funding.
Conflicts of Interest
The authors declare no conflict of interest.
Footnotes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Ghanemi A., Yoshioka M., St-Amand J. Broken Energy Homeostasis and Obesity Pathogenesis: The Surrounding Concepts. J. Clin. Med. 2018;7:453. doi: 10.3390/jcm7110453. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Ghanemi A., St-Amand J. Redefining obesity toward classifying as a disease. Eur. J. Intern. Med. 2018;55:20–22. doi: 10.1016/j.ejim.2018.05.025. [DOI] [PubMed] [Google Scholar]
- 3.Ambrosi T.H., Scialdone A., Graja A., Gohlke S., Jank A.-M., Bocian C., Woelk L., Fan H., Logan D.W., Schürmann A., et al. Adipocyte Accumulation in the Bone Marrow during Obesity and Aging Impairs Stem Cell-Based Hematopoietic and Bone Regeneration. Cell Stem Cell. 2017;20:771–784.e6. doi: 10.1016/j.stem.2017.02.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Tencerova M., Figeac F., Ditzel N., Taipaleenmäki H., Nielsen T.K., Kassem M. High-Fat Diet-Induced Obesity Promotes Expansion of Bone Marrow Adipose Tissue and Impairs Skeletal Stem Cell Functions in Mice. J. Bone Miner. Res. 2018;33:1154–1165. doi: 10.1002/jbmr.3408. [DOI] [PubMed] [Google Scholar]
- 5.Da Silva S.V., Renovato-Martins M., Ribeiro-Pereira C., Citelli M., Barja-Fidalgo C. Obesity modifies bone marrow microenvironment and directs bone marrow mesenchymal cells to adipogenesis. Obeity. 2016;24:2522–2532. doi: 10.1002/oby.21660. [DOI] [PubMed] [Google Scholar]
- 6.Ulum B., Teker H.T., Sarikaya A., Balta G., Kuşkonmaz B., Uckan D., Aerts-Kaya F. Bone marrow mesenchymal stem cell donors with a high body mass index display elevated endoplasmic reticulum stress and are functionally impaired. J. Cell. Physiol. 2018;233:8429–8436. doi: 10.1002/jcp.26804. [DOI] [PubMed] [Google Scholar]
- 7.Pérez L.M., Bernal A., Martín N.S., Gálvez B.G. Obese-derived ASCs show impaired migration and angiogenesis properties. Arch. Physiol. Biochem. 2013;119:195–201. doi: 10.3109/13813455.2013.784339. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Wu C.-L., Diekman B.O., Jain D., Guilak F. Diet-induced obesity alters the differentiation potential of stem cells isolated from bone marrow, adipose tissue and infrapatellar fat pad: The effects of free fatty acids. Int. J. Obes. 2012;37:1079–1087. doi: 10.1038/ijo.2012.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Ma S., Wong W.T., Wang D.H. Obesity reshapes stem cell extracellular vesicles. Cytom. Part A. 2018;93:177–179. doi: 10.1002/cyto.a.23166. [DOI] [PubMed] [Google Scholar]
- 10.Fuster J.J., Ouchi N., Gokce N., Walsh K. Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease. Circ. Res. 2016;118:1786–1807. doi: 10.1161/CIRCRESAHA.115.306885. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Iyengar N.M., Gucalp A., Dannenberg A.J., Hudis C.A. Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation. J. Clin. Oncol. 2016;34:4270–4276. doi: 10.1200/JCO.2016.67.4283. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Kraakman M.J., Murphy A.J., Jandeleit-Dahm K., Kammoun H.L. Macrophage Polarization in Obesity and Type 2 Diabetes: Weighing Down Our Understanding of Macrophage Function? Front. Immunol. 2014;5:470. doi: 10.3389/fimmu.2014.00470. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Esser N., Legrand-Poels S., Piette J., Scheen A., Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res. Clin. Pract. 2014;105:141–150. doi: 10.1016/j.diabres.2014.04.006. [DOI] [PubMed] [Google Scholar]
- 14.Varga T., Mounier R., Patsalos A., Gogolák P., Peloquin M., Horvath A., Pap A., Daniel B., Nagy G., Pintye E., et al. Macrophage PPARγ, a Lipid Activated Transcription Factor Controls the Growth Factor GDF3 and Skeletal Muscle Regeneration. Immunity. 2016;45:1038–1051. doi: 10.1016/j.immuni.2016.10.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Varga T., Mounier R., Gogolak P., Poliska S., Chazaud B., Nagy L. Tissue LyC6− Macrophages Are Generated in the Absence of Circulating LyC6− Monocytes and Nur77 in a Model of Muscle Regeneration. J. Immunol. 2013;191:5695–5701. doi: 10.4049/jimmunol.1301445. [DOI] [PubMed] [Google Scholar]
- 16.Varga T., Mounier R., Horvath A., Cuvellier S., Dumont F., Póliska S., Ardjoune H., Juban G., Nagy L., Chazaud B. Highly Dynamic Transcriptional Signature of Distinct Macrophage Subsets during Sterile Inflammation, Resolution, and Tissue Repair. J. Immunol. 2016;196:4771–4782. doi: 10.4049/jimmunol.1502490. [DOI] [PubMed] [Google Scholar]
- 17.Fu X., Zhu M., Zhang S., Foretz M., Viollet B., Du M. Obesity impairs skeletal muscle regeneration via inhibition of AMP-activated protein kinase. Diabetes. 2015;65:188–200. doi: 10.2337/db15-0647. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Xu P., Werner J.-U., Milerski S., Hamp C.M., Kuzenko T., Jähnert M., Gottmann P., De Roy L., Warnecke D., Abaei A., et al. Diet-Induced Obesity Affects Muscle Regeneration After Murine Blunt Muscle Trauma—A Broad Spectrum Analysis. Front. Physiol. 2018;9:674. doi: 10.3389/fphys.2018.00674. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Geiger A.E., Daughtry M.R., Yen C., Kirkpatrick L.T., Shi H., Gerrard D.E. Dual effects of obesity on satellite cells and muscle regeneration. Physiol. Rep. 2020;8:e14511. doi: 10.14814/phy2.14511. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Dungan C.M., Peck B.D., Walton R.G., Huang Z., Bamman M.M., Kern P.A., Peterson C.A. In vivo analysis of γH2AX+ cells in skeletal muscle from aged and obese humans. FASEB J. 2020;34:7018–7035. doi: 10.1096/fj.202000111RR. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Liu X., Qu H., Zheng Y., Liao Q., Zhang L., Liao X., Xiong X., Wang Y., Zhang R., Wang H., et al. Mitochondrial glycerol 3-phosphate dehydrogenase promotes skeletal muscle regeneration. EMBO Mol. Med. 2018;10:e9390. doi: 10.15252/emmm.201809390. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Duguez S., Féasson L., Denis C., Freyssenet D. Mitochondrial biogenesis during skeletal muscle regeneration. Am. J. Physiol. Metab. 2002;282:E802–E809. doi: 10.1152/ajpendo.00343.2001. [DOI] [PubMed] [Google Scholar]
- 23.Wagatsuma A., Kotake N., Yamada S. Muscle regeneration occurs to coincide with mitochondrial biogenesis. Mol. Cell. Biochem. 2010;349:139–147. doi: 10.1007/s11010-010-0668-2. [DOI] [PubMed] [Google Scholar]
- 24.Wagatsuma A., Kotake N., Kawachi T., Shiozuka M., Yamada S., Matsuda R. Mitochondrial adaptations in skeletal muscle to hindlimb unloading. Mol. Cell. Biochem. 2010;350:1–11. doi: 10.1007/s11010-010-0677-1. [DOI] [PubMed] [Google Scholar]
- 25.Hood D.A. Invited Review: Contractile activity-induced mitochondrial biogenesis in skeletal muscle. J. Appl. Physiol. 2001;90:1137–1157. doi: 10.1152/jappl.2001.90.3.1137. [DOI] [PubMed] [Google Scholar]
- 26.Hood D.A., Irrcher I., Ljubicic V., Joseph A.-M. Coordination of metabolic plasticity in skeletal muscle. J. Exp. Biol. 2006;209:2265–2275. doi: 10.1242/jeb.02182. [DOI] [PubMed] [Google Scholar]
- 27.Owens D.J., Sharples A.P., Polydorou I., Alwan N., Donovan T.F., Tang J., Fraser W.D., Cooper R.G., Morton J.P., E Stewart C., et al. A systems-based investigation into vitamin D and skeletal muscle repair, regeneration, and hypertrophy. Am. J. Physiol. Metab. 2015;309:E1019–E1031. doi: 10.1152/ajpendo.00375.2015. [DOI] [PubMed] [Google Scholar]
- 28.Pereira-Santos M., Costa P.R.F., Assis A.M.O., Santos C.A.S.T., Santos D.B. Obesity and vitamin D deficiency: A systematic review and meta-analysis. Obes. Rev. 2015;16:341–349. doi: 10.1111/obr.12239. [DOI] [PubMed] [Google Scholar]
- 29.Farrell N.J., Norris G.H., Ryan J., Porter C.M., Jiang C., Blesso C.N. Black elderberry extract attenuates inflammation and metabolic dysfunction in diet-induced obese mice. Br. J. Nutr. 2015;114:1123–1131. doi: 10.1017/S0007114515002962. [DOI] [PubMed] [Google Scholar]
- 30.Van Der Heijden R.A., Sheedfar F., Morrison M.C., Hommelberg P.P.H., Kor D., Kloosterhuis N.J., Gruben N., A Youssef S., De Bruin A., Hofker M.H., et al. High-fat diet induced obesity primes inflammation in adipose tissue prior to liver in C57BL/6j mice. Aging. 2015;7:256–268. doi: 10.18632/aging.100738. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Vieira-Potter V.J., Valentine R.J., Wilund K.R., Antao N., Baynard T., Woods J.A. Effects of exercise and low-fat diet on adipose tissue inflammation and metabolic complications in obese mice. Am. J. Physiol. Metab. 2009;296:E1164–E1171. doi: 10.1152/ajpendo.00054.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Perandini L.A., Chimin P., Lutkemeyer D.D.S., Câmara N.O.S. Chronic inflammation in skeletal muscle impairs satellite cells function during regeneration: Can physical exercise restore the satellite cell niche? FEBS J. 2018;285:1973–1984. doi: 10.1111/febs.14417. [DOI] [PubMed] [Google Scholar]
- 33.Polyzos S.A., Margioris A.N. Sarcopenic obesity. Hormones. 2018;17:321–331. doi: 10.1007/s42000-018-0049-x. [DOI] [PubMed] [Google Scholar]
- 34.Hong S.-H., Choi K.M. Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences. Int. J. Mol. Sci. 2020;21:494. doi: 10.3390/ijms21020494. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Hurr C., Simonyan H., Morgan D.A., Rahmouni K., Young C.N. Liver sympathetic denervation reverses obesity-induced hepatic steatosis. J. Physiol. 2019;597:4565–4580. doi: 10.1113/JP277994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Khoo N.K., Fazzari M., Chartoumpekis D.V., Li L., Guimaraes D.A., Arteel G.E., Shiva S., Freeman B.A. Electrophilic nitro-oleic acid reverses obesity-induced hepatic steatosis. Redox Biol. 2019;22:101132. doi: 10.1016/j.redox.2019.101132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Allaire M., Gilgenkrantz H. The impact of steatosis on liver regeneration. Horm. Mol. Biol. Clin. Investig. 2018;41 doi: 10.1515/hmbci-2018-0050. [DOI] [PubMed] [Google Scholar]
- 38.Lee Y., Berglund E.D., Yu X., Wang M.-Y., Evans M.R., Scherer P.E., Holland W.L., Charron M.J., Roth M.G., Unger R.H. Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells. Proc. Natl. Acad. Sci. USA. 2014;111:13217–13222. doi: 10.1073/pnas.1409638111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Sáinz N., Barrenetxe J., Moreno-Aliaga M.J., Martínez J.A. Leptin resistance and diet-induced obesity: Central and peripheral actions of leptin. Metabolism. 2015;64:35–46. doi: 10.1016/j.metabol.2014.10.015. [DOI] [PubMed] [Google Scholar]
- 40.Raut P.K., Kim S.-H., Choi D.Y., Jeong G.-S., Park P.-H. Growth of breast cancer cells by leptin is mediated via activation of the inflammasome: Critical roles of estrogen receptor signaling and reactive oxygen species production. Biochem. Pharmacol. 2019;161:73–88. doi: 10.1016/j.bcp.2019.01.006. [DOI] [PubMed] [Google Scholar]
- 41.Barrios-Correa A.A., Estrada J.A., Contreras I. Leptin Signaling in the Control of Metabolism and Appetite: Lessons from Animal Models. J. Mol. Neurosci. 2018;66:390–402. doi: 10.1007/s12031-018-1185-0. [DOI] [PubMed] [Google Scholar]
- 42.Pérez-Pérez A., Vilariño-García T., Fernández-Riejos P., Martín-González J., Segura-Egea J.J., Sánchez-Margalet V. Role of leptin as a link between metabolism and the immune system. Cytokine Growth Factor Rev. 2017;35:71–84. doi: 10.1016/j.cytogfr.2017.03.001. [DOI] [PubMed] [Google Scholar]
- 43.Titchenell P.M., Lazar M.A., Birnbaum M.J. Unraveling the Regulation of Hepatic Metabolism by Insulin. Trends Endocrinol. Metab. 2017;28:497–505. doi: 10.1016/j.tem.2017.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Laron Z., Werner H. Insulin: A Growth Hormone and Potential Oncogene. Pediatr. Endocrinol. Rev. 2020;17:191–197. doi: 10.17458/per.vol17.2020.lw.insulinghpotentialoncogene. [DOI] [PubMed] [Google Scholar]
- 45.Tencerova M., Okla M., Kassem M. Insulin Signaling in Bone Marrow Adipocytes. Curr. Osteoporos. Rep. 2019;17:446–454. doi: 10.1007/s11914-019-00552-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Proietto J., Tencerova M., Frost M., Figeac F., Nielsen T.K., Ali D., Lauterlein J.L., Andersen T.L., Haakonsson A.K., Rauch A., et al. Faculty Opinions recommendation of Obesity-Associated Hypermetabolism and Accelerated Senescence of Bone Marrow Stromal Stem Cells Suggest a Potential Mechanism for Bone Fragility. Fac. Opin. Post-Publ. Peer Rev. Biomed. Lit. 2020;27:2050–2062. doi: 10.3410/f.735771420.793577684. [DOI] [PubMed] [Google Scholar]
- 47.Cornish J., Wang T., Lin J.-M. Role of Marrow Adipocytes in Regulation of Energy Metabolism and Bone Homeostasis. Curr. Osteoporos. Rep. 2018;16:116–122. doi: 10.1007/s11914-018-0425-0. [DOI] [PubMed] [Google Scholar]
- 48.Muruganandan S., Govindarajan R., Sinal C.J., Shanmugam M., Rajgopal G. Bone Marrow Adipose Tissue and Skeletal Health. Curr. Osteoporos. Rep. 2018;16:434–442. doi: 10.1007/s11914-018-0451-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Röszer T., Józsa T., Kiss-Tóth E.D., De Clerck N., Balogh L. Leptin receptor deficient diabetic (db/db) mice are compromised in postnatal bone regeneration. Cell Tissue Res. 2013;356:195–206. doi: 10.1007/s00441-013-1768-6. [DOI] [PubMed] [Google Scholar]
- 50.Avgerinos K.I., Spyrou N., Mantzoros C.S., Dalamaga M. Obesity and cancer risk: Emerging biological mechanisms and perspectives. Metabolism. 2019;92:121–135. doi: 10.1016/j.metabol.2018.11.001. [DOI] [PubMed] [Google Scholar]
- 51.Li H.-M., Ye Z.-H. Microenvironment of liver regeneration in liver cancer. Chin. J. Integr. Med. 2017;23:555–560. doi: 10.1007/s11655-017-2806-0. [DOI] [PubMed] [Google Scholar]
- 52.Boilly B., Faulkner S., Jobling P., Hondermarck H. Nerve Dependence: From Regeneration to Cancer. Cancer Cell. 2017;31:342–354. doi: 10.1016/j.ccell.2017.02.005. [DOI] [PubMed] [Google Scholar]
- 53.Gao F., Lv T.-R., Zhou J.-C., Qin X.-D. Effects of obesity on the healing of bone fracture in mice. J. Orthop. Surg. Res. 2018;13:145. doi: 10.1186/s13018-018-0837-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Yu H., Harrison F.E., Xia F. Altered DNA repair; an early pathogenic pathway in Alzheimer’s disease and obesity. Sci. Rep. 2018;8:1–6. doi: 10.1038/s41598-018-23644-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Włodarczyk M., Nowicka G. Obesity, DNA Damage, and Development of Obesity-Related Diseases. Int. J. Mol. Sci. 2019;20:1146. doi: 10.3390/ijms20051146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Ling C., Rönn T. Epigenetics in Human Obesity and Type 2 Diabetes. Cell Metab. 2019;29:1028–1044. doi: 10.1016/j.cmet.2019.03.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Mazon J.N., De Mello A.H., Ferreira G.K., Rezin G.T. The impact of obesity on neurodegenerative diseases. Life Sci. 2017;182:22–28. doi: 10.1016/j.lfs.2017.06.002. [DOI] [PubMed] [Google Scholar]
- 58.Payab M., Goodarzi P., Heravani N.F., Hadavandkhani M., Zarei Z., Falahzadeh K., Larijani B., Rahim F., Arjmand B. Stem Cell and Obesity: Current State and Future Perspective. Atherosclerosis. 2018;1089:1–22. doi: 10.1007/5584_2018_227. [DOI] [PubMed] [Google Scholar]
- 59.Matsushita K., Dzau V.J. Mesenchymal stem cells in obesity: Insights for translational applications. Lab. Investig. 2017;97:1158–1166. doi: 10.1038/labinvest.2017.42. [DOI] [PubMed] [Google Scholar]
- 60.Ghanemi A., Melouane A., Mucunguzi O., Yoshioka M., St-Amand J. Energy and metabolic pathways in trefoil factor family member 2 (Tff2) KO mice beyond the protection from high-fat diet-induced obesity. Life Sci. 2018;215:190–197. doi: 10.1016/j.lfs.2018.11.006. [DOI] [PubMed] [Google Scholar]
- 61.Ahmad A., Ali T., Kim M.W., Khan A., Jo M.H., Rehman S.U., Khan M.S., Bin Abid N., Khan M., Ullah R., et al. Adiponectin homolog novel osmotin protects obesity/diabetes-induced NAFLD by upregulating AdipoRs/PPARα signaling in ob/ob and db/db transgenic mouse models. Metabolism. 2019;90:31–43. doi: 10.1016/j.metabol.2018.10.004. [DOI] [PubMed] [Google Scholar]